Tomas Kobo, President of the General Council of Official Colleges of Physicians (CGCom).
medical cannabis integration Surrounded by unknown people still in the National Health System (SNS). Despite the fact that the Congress of Deputies approved a report in late June that supported its use for medical purposes, the decision lacks approval from the group of doctors who recommend using this formula only for treatment. agree to. A very typical childhood pathology.
President of the General Council of Official Colleges of Physicians (CGCom), Thomas Cobb, have explained to medical writing It is the only pathological field in which it is demonstrated with “concrete scientific evidence”., that this type of treatment might work is that of pediatric patients Persistent status epilepticus Those who do not respond to any other type of medicine.
Kobo outlines that even for this specific group of patients, medical cannabis Result “It is impossible to determine in the long run what the impact will be They produce because the mortality rate in these cases is very high.”
The leader of the collegiate body warns that the rest are only for diseases “Hints” about its possible use But not the necessary certainties to implement it. “Cannabis is strictly prohibited for very specific pathologies in which the benefits of its use are demonstrated with no scientific evidence,” he explained.
Skeptics of collegiate medical organizations thus add to the criticism that certain groups of the profession have already done in a private capacity. Spanish Society of Pulmonology and Thoracic Surgery (Seper) has already become one of the main opponents of its regulation “Serious threat to physical and mental health” which represents their opinion to the public. While he paid special attention to teenagers.
Therapeutic uses of medicinal cannabis
The starting point of the medical sector collides head-on with the roadmap set by the health commission in late June after months of debate with the presence of various experts. The document proposes its application for a wide range of patients like pathology multiple sclerosis, some form of epilepsy, causing nausea or vomiting chemotherapy oh so endometriosis, Key innovations include joining a group of people who have chronic pain like oncological patients.
Parliamentary groups defined these potential beneficiaries of medical cannabis because they had “Strong Signs of Usefulness”, But they left the door open for new therapeutic indications to be included as soon as they were published. scientific study which provide new data on its effectiveness.
The lesson progressed thanks to the support of two groups, which c. make upgovernment alliance (PSOE and United We Can), which were also added Citizen, PNV and PDECAT. because of the lack of support for their initiative CKD and HD Build while he avoided Popular Party and Vox He was the only one who rejected the whole opinion. Whatever be the case, the final decision will rest with the Health Ministry.
While it may include statements, data or notes from health institutions or professionals, the information contained in medical writing is edited and prepared by journalists. We advise the reader to consult a health professional on any health-related questions.